Literature DB >> 27895337

Equivalence of BCSH and WHO diagnostic criteria for ET.

C N Harrison1, M F McMullin2, A R Green3, A J Mead4.   

Abstract

Mesh：

Year:  2016        PMID： 27895337     DOI： 10.1038/leu.2016.318

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  Guideline for investigation and management of adults and children presenting with a thrombocytosis.

Authors:  Claire N Harrison; David Bareford; Nauman Butt; Peter Campbell; Eibhlean Conneally; Mark Drummond; Wendy Erber; Tamara Everington; Anthony R Green; Georgina W Hall; Beverley J Hunt; Christopher A Ludlam; Richard Murrin; Catherine Nelson-Piercy; Deepti H Radia; John T Reilly; Jon Van der Walt; Bridget Wilkins; Mary F McMullin
Journal:  Br J Haematol       Date:  2010-03-15       Impact factor: 6.998

2.  Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification.

Authors:  Jürgen Thiele; Hans Michael Kvasnicka; Leonhard Müllauer; Veronika Buxhofer-Ausch; Bettina Gisslinger; Heinz Gisslinger
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

3.  European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis.

Authors:  Thomas Buhr; Konnie Hebeda; Vassiliki Kaloutsi; Anna Porwit; Jon Van der Walt; Hans Kreipe
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

4.  How I treat essential thrombocythemia.

Authors:  Philip A Beer; Wendy N Erber; Peter J Campbell; Anthony R Green
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

5.  World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experience.

Authors:  Ann Brinch Madelung; Henrik Bondo; Inger Stamp; Preben Loevgreen; Signe Ledou Nielsen; Anne Falensteen; Helle Knudsen; Mats Ehinger; Rasmus Dahl-Sørensen; Nana Brochmann Mortensen; Kira Dynnes Svendsen; Theis Lange; Elisabeth Ralfkiaer; Karsten Nielsen; Hans Carl Hasselbalch; Jürgen Thiele
Journal:  Am J Hematol       Date:  2013-09-30       Impact factor: 10.047

6.  Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.

Authors:  Bridget S Wilkins; Wendy N Erber; David Bareford; Georgina Buck; Keith Wheatley; Clare L East; Beverley Paul; Claire N Harrison; Anthony R Green; Peter J Campbell
Journal:  Blood       Date:  2007-09-20       Impact factor: 22.113

7.  Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.

Authors:  Claire N Harrison; Nauman Butt; Peter Campbell; Eibhlin Conneally; Mark Drummond; Anthony R Green; Richard Murrin; Deepti H Radia; Adam Mead; John T Reilly; Nicholas C P Cross; Mary F McMullin
Journal:  Br J Haematol       Date:  2014-06-17       Impact factor: 6.998

8.  Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.

Authors:  H Gisslinger; G Jeryczynski; B Gisslinger; A Wölfler; S Burgstaller; V Buxhofer-Ausch; M Schalling; M-T Krauth; A-I Schiefer; C Kornauth; I Simonitsch-Klupp; C Beham-Schmid; L Müllauer; J Thiele
Journal:  Leukemia       Date:  2015-12-29       Impact factor: 11.528
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.